June 29, 2022
Solasia Pharma and Nippon Kayaku said on June 28 that they have inked an agreement to form a capital and business alliance to boost their collaboration in drug R&D and commercialization. Under the deal, Nippon Kayaku will obtain an 8.42%...read more